Worcester’s Massachusetts Biomedical Initiatives (MBI) to Receive MassBio’s Leading Impact Award
Honor recognizes commitment to strengthening the MA life sciences supercluster
March 12, 2013 (CAMBRIDGE, MA) – Massachusetts Biomedical Initiatives (MBI) will be honored for its significant contribution and commitment to improving the competitiveness of Massachusetts as a destination for the life sciences industry with the MassBio Leading Impact Award, the trade association announced today.
MBI President & CEO Kevin O’Sullivan will accept the award during MassBio’s Annual Meeting on Thursday, March 14th at the Royal Sonesta Hotel, 40 Edwin Land Blvd, Cambridge, MA.
The Leading Impact Award was developed by MassBio’s Economic Development Advisory Group (EDAG) to annually recognize significant contributions made by innovative organizations within the industry, and in the arena of property development and local, regional, and state economic development, that have successfully worked to improve the ecosystem for industry growth in Massachusetts.
“MBI has fostered entrepreneurship and life sciences startups in MA for almost three decades, helping dozens of companies to become established and to grow,” said Mark R. Bamforth, EDAG Chairman and President & CEO of Gallus Pharmaceuticals. “It took foresight and courage to create a biotech hub in Worcester which complements the growth of the industry in Cambridge and around the Commonwealth. Kevin O’Sullivan has been a stalwart advocate for strong regional growth.”
Massachusetts Biomedical Initiatives (MBI) in Worcester, is a private, independent economic development organization dedicated to job creation and innovative healthcare throughout Massachusetts by promoting the growth of start-up biomedical companies. MBI operates three life science business incubator facilities in Worcester that are home to twenty companies with approximately 100 employees. Through its incubator facilities, MBI lowers barriers to success for emerging companies by providing cost-effective, high quality laboratory space and support services.
“The Leading Edge Award is a great tribute to our entrepreneurial MBI tenant companies - past and present, who commercialize their science by way of creating innovative companies and jobs while in turn helping to grow our Massachusetts economy,” said Kevin O’Sullivan, President & CEO of MBI. “We are grateful to MassBio for this recognition and look forward to continuing to work with them in fulfilling our economic mission.”
MBI was nominated for the award by the team at the City of Worcester.
“MBI was and remains instrumental in establishing Worcester as a premier biotechnology center,” said Timothy J. McGourthy, Chief Development Officer of the City of Worcester. “Under Kevin O’Sullivan’s leadership MBI has become a center for collaboration and innovation. MBI’s promotion of new start-ups, institutional partnerships, and tireless advocacy is transforming the future of healthcare worldwide as well as stimulating job growth in Worcester and throughout the Commonwealth.”
MBI is the second organization to receive this award. Last year’s winner was Pfizer's Center for Therapeutic Innovation (CTI) in Boston, MA.